nonoxynol has been researched along with Genital Herpes in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheshenko, N; Fakioglu, E; Herold, BC; Keller, MJ; Mesquita, PM; Wilson, SS | 1 |
| Langenberg, A | 1 |
| De Deken, B; Gouws, E; Karim, SA; Ramjee, G; Van Dyck, E; Williams, B | 1 |
| Abusuwwa, R; Anderson, DJ; Cone, RA; Hoen, T; Moench, TR; Wong, X | 1 |
| Galen, BT; Garin, A; Guzman, E; Hazrati, E; Herold, BC; Keller, MJ; Lira, SA; Martin, AP; Porter, DD; Wilson, SS | 1 |
| Barratt, RA; Cone, RA; Hoen, TE; Whaley, KJ; Zeitlin, L | 1 |
| Wittkowski, KM | 1 |
| Cone, RA; Hegarty, TA; Moench, TR; Whaley, KJ; Zeitlin, L | 1 |
| Phillips, DM; Zacharopoulos, VR | 1 |
| Maguire, RA; Phillips, DM; Zacharopoulos, VR | 1 |
| Whaley, KJ; Zeitlin, L | 1 |
| Davies, KS; DeLong, ER; Rekart, ML; Sacks, SL; Sellers, PW; Stiver, HG; Varner, TL | 1 |
| Czelusniak, SM; Friedman-Kien, AE; Glaser, RD; Klein, RJ | 1 |
2 review(s) available for nonoxynol and Genital Herpes
| Article | Year |
|---|---|
Interrupting herpes simplex virus type 2 transmission: the role of condoms and microbicides.
Topics: Anti-Infective Agents; Antibodies, Monoclonal; Condoms; Female; Herpes Genitalis; Humans; Male; Nonoxynol; Seroepidemiologic Studies | 2004 |
Microbicides for preventing transmission of genital herpes.
Topics: Administration, Intravaginal; Animals; Antibodies, Monoclonal; Antiviral Agents; Herpes Genitalis; Humans; Models, Animal; Nonoxynol; Simplexvirus; Species Specificity; Spermatocidal Agents | 2002 |
3 trial(s) available for nonoxynol and Genital Herpes
| Article | Year |
|---|---|
The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seropositivity; HIV-1; Humans; Middle Aged; Nonoxynol; Proportional Hazards Models; Risk Factors; Sex Work; South Africa; Time Factors; Vaginal Creams, Foams, and Jellies | 2005 |
Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Herpes Genitalis; Humans; Interferon Type I; Male; Middle Aged; Nonoxynol; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recurrence; Sex Factors | 1990 |
Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9.
Topics: Administration, Topical; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Gels; Herpes Genitalis; Humans; Interferon Type I; Male; Nonoxynol; Polyethylene Glycols | 1986 |
8 other study(ies) available for nonoxynol and Genital Herpes
| Article | Year |
|---|---|
Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
Topics: Adenine; Administration, Intravaginal; Animals; Anti-Infective Agents; Antiviral Agents; Biomarkers; Disease Models, Animal; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Mice; Mice, Inbred BALB C; Naphthalenesulfonates; Nonoxynol; Organophosphonates; Polymers; Predictive Value of Tests; Risk Assessment; Tenofovir | 2009 |
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.
Topics: Animals; Cellulose; Detergents; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Mice; Nonoxynol; Polystyrenes; Surface-Active Agents; Vagina | 2006 |
A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Disease Susceptibility; Female; Herpes Genitalis; Mice; Models, Animal; NF-kappa B; Nonoxynol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sexually Transmitted Diseases, Viral; Transcription Factor AP-1; Vagina; Vaginal Creams, Foams, and Jellies; Vaginitis | 2007 |
Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections.
Topics: Animals; Female; Herpes Genitalis; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Nonoxynol; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Simplexvirus; Vagina | 1993 |
The efficacy of nonoxynol-9 from an in vivo point of view.
Topics: Female; Gonorrhea; Herpes Genitalis; HIV Infections; Humans; In Vitro Techniques; Male; Nonoxynol; Sexually Transmitted Diseases; Spermatocidal Agents; Trichomonas Vaginitis | 1997 |
Tests of vaginal microbicides in the mouse genital herpes model.
Topics: Animals; Anti-Infective Agents; Antibodies, Monoclonal; Antiviral Agents; Carrageenan; Chlorhexidine; Concanavalin A; Female; Herpes Genitalis; Herpesvirus 2, Human; Lactoglobulins; Mice; Mice, Inbred C57BL; Nonoxynol; Polysaccharides; Polystyrenes; Povidone-Iodine; Vagina | 1997 |
Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice.
Topics: Animals; Epithelium; Herpes Genitalis; Herpesvirus 2, Human; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Mucous Membrane; Nonoxynol; Rectal Diseases; Rectum | 1998 |
Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections.
Topics: Animals; Carrageenan; Chemistry, Pharmaceutical; Drug Synergism; Female; Herpes Genitalis; Mice; Mice, Inbred BALB C; Nonoxynol; Sexually Transmitted Diseases, Viral; Spermatocidal Agents | 1998 |